Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children

University of North Carolina, Chapel Hill65 enrolled

Overview

This is a prospective study to determine the accuracy of the Masimo Pronto Non-Invasive Hemoglobin Monitor and associated Rainbow® probes in the detection of hemoglobin concentration in critically ill children. Data from at least 30 patients admitted to the Pediatric Intensive Care Unit (PICU) over a period of 2 months will be collected and analyzed for this study. Note, that this device would not lead to deviations in routine patient care; specifically, the non-invasive monitor placed on the patient's finger is FDA approved. The proposed monitors are identical macroscopically to monitors, which are currently used to measure oxygen saturation at this institution. Clinical decisions, additional blood draws or alterations to the plan of care will not be made based on study data. The objective is to compare the validity of the hemoglobin values determined from non-invasive technology with measured laboratory values for hemoglobin utilized as standard of care.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hemoglobin Results

Interventions

Masimo Pronto Rad 7 Non-Invasive hemoglobin monitorOTHER

Patients admitted to PICU requiring hemoglobin monitoring will have a total hemoglobin (SpHb) assessment from Masimo non-invasive monitor, prior to standard, required blood draw and laboratory analysis.

Standard Laboratory Blood Draw and Hemoglobin AnalysisOTHER

Patients admitted to PICU requiring hemoglobin monitoring will have a reading from Masimo non-invasive monitor, prior to standard, required blood draw and laboratory analysis.

Eligibility

Sex: ALLMin age: 30 DaysMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has been admitted to Pediatric Intensive Care Unit * Patient age is ≥ 30 days old and ≤ 18 years old * Patient weight ≥ 3 Kg. * Patient requires hemoglobin monitoring Exclusion Criteria: * Patient does not have exposed fingers/toes,due to congenital anomalies wound dressing or injury. * Patient weight is less than 3 Kg * Patient is less than 30 days old

Locations (1)

Pediatric Intensive Care Unit, University of North Carolina

Chapel Hill, North Carolina, United States

Outcomes

Primary Outcomes

Comparison of standard hemoglobin monitoring vs. the MASIO non-invasive hemoglobin monitor

We will obtain measurements using the Masimo Pronto device prior to the standard lab draw at the following time points: post admission to PICU, 12-48 hours. We will then perform analysis using Bland Altman methods to determine the degree of agreement. Data analysis will occur 1 year after enrollment completion.

Time frame: up to 48 hours, post PICU admission

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.